300267 爾康製藥
按盤價 
4.240 -0.450 (-9.595%)
4.240 -0.450 (-9.595%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.631 | -8.044 | -3.951 | 0.928 | -14.841 |
| 總資產報酬率 ROA (%) | 0.545 | -6.993 | -3.446 | 0.814 | -13.090 |
| 投入資產回報率 ROIC (%) | 0.560 | -7.235 | -3.606 | 0.856 | -13.752 | 邊際利潤分析 |
| 銷售毛利率 (%) | 26.135 | 27.523 | 20.424 | 22.220 | 23.341 |
| 營業利潤率 (%) | 7.419 | -32.521 | -11.593 | 0.737 | -36.619 |
| 息稅前利潤/營業總收入 (%) | 7.853 | -34.032 | -11.151 | 1.634 | -37.606 |
| 淨利潤/營業總收入 (%) | 6.772 | -34.453 | -12.442 | 1.982 | -35.710 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 58.207 | 19.107 | 56.875 | -66.062 | -4.149 |
| 價值變動淨收益/利潤總額(%) | 10.009 | 14.277 | 4.561 | 108.424 | -2.050 |
| 營業外收支淨額/利潤總額(%) | 1.349 | 4.511 | -3.917 | 20.596 | 3.219 | 償債能力分析 |
| 流動比率 (X) | 2.710 | 2.434 | 2.869 | 2.883 | 3.901 |
| 速動比率 (X) | 1.625 | 1.583 | 1.723 | 1.750 | 2.468 |
| 資產負債率 (%) | 13.847 | 15.338 | 12.211 | 13.740 | 10.278 |
| 帶息債務/全部投入資本 (%) | 8.739 | 10.043 | 7.075 | 7.715 | 5.016 |
| 股東權益/帶息債務 (%) | 1,023.550 | 877.575 | 1,295.790 | 1,177.652 | 1,870.734 |
| 股東權益/負債合計 (%) | 629.147 | 557.642 | 722.818 | 627.794 | 868.961 |
| 利息保障倍數 (X) | 23.571 | -1,336.839 | -2,082.766 | 2.314 | -162.266 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 31.061 | 33.538 | 24.515 | 30.811 | 43.507 |
| 存貨周轉天數 (天) | 219.133 | 281.647 | 191.927 | 190.048 | 154.502 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 01/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
